《大行報告》高盛:青啤(0168.HK)首季業績勝預期 目標價上調至86.2元
青啤(0168.HK)首季銷售及純利按年分別增長42%及90%,升幅高於該行預期,銷售及息稅前盈利亦高於2019年首季升幅,該行相信反映了青啤將自今年起錄得強勁反彈。不過該行認為青啤於次季將面對較高基數,或影響增長數字,加上行業亦將投資於高端品牌,料青啤次季增長將較慢。
基於首季表現強勁,該行上調2021年至2023年每股盈利預測8%至9%,料今年全年持續經營業務EBIT按年增長27%,目標價自81.3元上調至86.2元,評級「中性」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.